AZT inhibits the transmission of human T cell leukaemia/lymphoma virus type I to adult peripheral blood mononuclear cells in vitro

Journal of General Virology

Volumn 78, Issue 5, 1997, Pages 1007-1016

  Macchi, Beatrice ^a,b   Faraoni, Isabella ^a   Zhang, Jing ^a   Grelli, Sandro ^c   Favalli, Cartesio ^a,b   Mastino, Antonio ^d   Bonmassar, Enzo ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c CNR   (Italy)

^d UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR; RECOMBINANT INTERLEUKIN 2; VIRUS DNA; VIRUS RNA; ZIDOVUDINE;

ANTIGEN EXPRESSION; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; MONONUCLEAR CELL; NONHUMAN; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROVIRUS; VIRUS TRANSMISSION;

EID: 0030989310     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-78-5-1007     Document Type: Article

References (39)

1. Chi, D. T. & Duesberg, P. H. (1995). The toxicity of azidothymidine (AZT) on human and animal cells in culture at concentrations used for antiviral therapy. Genetica 95, 103-109.
2. Cooney, D. A., Ahluwalia, G., Mitsuya, H., Friland, A., Johnson, M., Hao, Z., Dalal, M., Balzarini, J., Broder, S. & Johns, D. G. (1987). Initial studies of the cellular pharmacology of 2′-3′-dideoxyadenosine, an inhibitor of HIV infectivity. Biochemical Pharmacology 36, 1765-1768.
3. Depper, J. M., Leonard, W. J., Kronke, M., Waldmann, T. A. & Greene, W. C. (1984). Augmented T cell growth factor receptor expression in HTLV-1 infected human leukemic T cells. Journal of Immunology 133, 1691-1695.
4. Dianzani, F., Antonelli, G., Turriziani, O., Riva, E., Simeoni, E., Signoretti, C., Strosselli, S. & Cianfriglia, M. (1994). Zidovudine induces the expression of cellular resistance affecting its antiviral activity. Aids Research and Human Retroviruses 10, 1471-1478.
5. Fischl, M. A., Richman, D. D., Grieco, M. H., Gottlieb, M. S., Volberding, P. A., Laskin, O. L., Leedon, J. M., Groopman, J. E., Mildvan, D., Schooley, R. T., Jackson, G. G., Durack, D. T., King D. & the AZT collaborative working group (1987). The efficacy of azidothymidine (AZT) in treatments of patients with AIDS and AIDS-related complex. New England Journal of Medicine 317, 185-191.
6. Franchini, G. (1995). Molecular mechanisms of human T-cell leukemia/lymphoma virus type I infection. Blood 86, 3619-3639.
7. Gill, S. P., Harrington, W. J. R., Kaplan, M. H., Ribeiro, R. C., Bennet, J. M., Liebman, H. A., Berstein-Singer, M., Espina, B. M., Cabral, L., Allen, S., Kornblau, S., Pike, M. C. & Levine, A. M. (1995). Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. New England Journal of Medicine 332, 1744-1748.
8. Heagy, W., Crumpacker, C., Lopez, P. A. & Finberg, R. W. (1991). Inhibition of immune functions by antiviral drugs. Journal of Clinical Investigation 87, 1916-1924.
9. Hermine, O., Bouscary, D., Gessain, A., Turlure, P., Leblond, V., Franck, N., Buzyn-Veil, A., Macintyre, E., Dreyfus, F. & Bazarbachi, A. (1995). Brief report: treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa. New England Journal of Medicine 332, 1749-1751.
10. Hino, S., Yamaguchi, K., Katamine, S., Sugiyama, H., Amagasaki, T., Kinoshita, K., Yoshida, Y., Doi, H., Tsuji, Y. & Miyamoto, T. (1985). Mother to child transmission of human T-cell leukemia virus type I. Japanese Journal of Cancer Research 76, 474-480.
11. Hoffman, P. M., Dhib-Jalbut, S., Mikovitis, J. A., Robbins, D. S., Wolf, A. L., Bergey, G. H., Lohrey, N. C., Wieslow, O. S. & Ruscetti, F. W. (1992). Human T-cell leukemia virus type I infection of monocytes and microglial cells in primary human cultures. Proceedings of the National Academy of Sciences, USA 89, 11784-11788.
12. Hoxie, J. A., Matthews, D. M. & Cines, D. B. (1984). Infection of human endothelial cells by human T-cell leukemia virus type I. Proceedings of the National Academy of Sciences, USA 81, 7591-7595.
13. Isono, T., Ogawa, K. & Seto, A. (1990). Antiviral effect of zidovudine in the experimental model of adult T cell leukemia in rabbits. Leukemia Research 14, 841-847.
14. Jacobson, S., Raine, C. S., Mingioli, E. S. & McFarlin, D. E. (1988). Isolation of an HTLV-I-like retrovirus from patients with tropical spastic paraparesis. Nature 331, 540-543.
15. Kimata, J. T. & Ratner, L. (1991). Temporal regulation of viral and cellular gene expression during human T-lymphotropic virus type-I mediated lymphocyte immortalization. Journal of Virology 65, 4398-4407.
16. Lacal, P. M., Puglianiello, A., Bonmassar, E. & D'Onofrio, C. (1995). Effects of cyclopentanone prostaglandins on myeloid cells during early infection with HTLV-I. I. Cell differentiation determines sensitivity to prostaglandins and virus infection. Journal of Pharmacology and Experimental Therapeutics 271, 1086-1095.
17. Macchi, B., Popovic, M., Allavena, P., Ortaldo, J., Rossi, P., Gallo, R. C. & Bonmassar, E. (1987). In vitro susceptibility of different human T-cell subpopulations and resistance of large granular lymphocytes to HTLV-I infection. International Journal of Cancer 40, 1-6.
18. Macchi, B., D'Onofrio, C., Labianca, R. A. & Bonmassar, E. (1990). Mononuclear cells from peripheral blood of adult donors and from neonatal cord blood are equally protected by alfa and beta interferon against infection with HTLV-I. Pharmacological Research 22, 503-514.
19. Macchi, B., D'Atri, S., Gentili, G. & Bonmassar, E. (1991). Determination of intracellular p19 core protein in HTLV-I infected cells by flow microcytometry analysis. Journal of Chemotherapy 3, 416-419.
20. Macchi, B., Caronti, B., Cocchia, D., Gremo, F., Torelli, S., Sogos, V., Bonmassar, E. & Lauro, G. M. (1992). Correlation between p19 presence and MHC class II expression in human fetal astroglial cells cocultured with HTLV-I-donor cells. International Journal of Developmental Neuroscience 10, 764-767.
21. + T cells isolated from human cord blood. Cancer Immunology Immunotherapy 37, 97-104.
22. Matsushita, S., Mitsuya, H., Reitz, M. S. & Broder, S. (1987). Pharmacological inhibition of in vitro infectivity of human T-lymphotropic virus type I. Journal of Clinical Investigation 80, 394-400.
23. Mitsuya, H., Weinhold, K. J., Furman, P. A., St Clair, M. H., Lehram, S. N., Gallo, R. C., Bolognesi, D., Barry, D. W. & Broder S. (1985). 3′-Azido-3′-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and the cytopathic effect of human T-lymphotropic virus type III/lymphoadenopathy-associated virus in vitro. Proceedings of the National Academy of Sciences, USA 82, 7906-8100.
24. Miyoshi, I., Kubonishi, I., Yoshimoto, S., Akagi, T., Outsuki, Y., Shirashy, Y., Nagata, K. & Hinuma, Y. (1981). Detection of type C retrovirus particles on a cord blood T-cell line derived by cocultivation of normal human lymphocytes and human leukemic T-cells. Nature 296, 770-772.
25. Nishioka, K., Maruyama, I., Sato, K., Kitajiama, Y., Nakajiama, Y. & Osame, M. (1989). Chronic inflammatory arthropathy associated with HTLV-I. Lancet i, 441.
26. Okochi, K., Sato, H. & Hinuma, Y. (1984). A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: seroconversion in recipients. Vox Sanguinis 46, 245-253.
27. Osame, M., Izumo, S., Igata, A., Matsumoto, M., Matsumoto, T., Sonoda, S., Tara, M. & Shibata, Y. (1986). Blood transfusion and HTLV-1 associated myelopathy. Lancet ii, 104-105.
28. Osame, M., Usuku, K., Izumo, S., Ijichi, N., Amitani, H. & Igata, A. (1986 b). HTLV-I associated myelopathy, a new clinical entity. Lancet i, 1031-1032.
29. Pesce, C., Ciprani, F., D'Onofrio, C., Alvino, E., Perno, C. F., Bonmassar, E. & Caliò, R. (1987). Low concentration of suramin can reduce in vitro infection of human cord blood lymphocytes with HTLV-I during long-term culture. Antiviral Research 8, 247-260.
30. Poiesez, B. J., Ruscetti, F. W., Gadzar, A. F., Bunn, P. A., Minna, J. D. & Gallo, R. C. (1980). Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proceedings of the National Academy of Sciences, USA 77, 7415-7419.
31. Poli, G., Orenstein, J. M., Kinter, A., Folks, T. M. & Fauci, A. (1989). Interferon-α but not AZT suppresses HIV expression in chronically infected cell lines. Science 244, 575-577.
32. Sagawa, K., Mochizuki, M., Masuoka, K., Katagiri, K., Katayama, T., Maeda, T., Tanimoto, A., Sugita, S., Watanabe, T. & Itoh, K. (1995). Immunopathological mechanism of human T cell lymphotropic virus type I (HTLV-I) uveitis. Detection of HTLV-I infected cells in the eye and their constitutive cytokine production. Journal of Clinical Investigation 95, 852-858.
33. Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
34. Silvestri, I., Albonici, L., Ciotti, M., Lombardi, M. P., Sinibaldi, P., Manzari, V., Orlando, P., Carretta, F., Strazzullo, G. & Grippo, P. (1995). Antimitotic and antiviral activities of Kelletinin A in HTLV-I infected MT-2 cells. Experientia 51, 1076-1780.
35. Sodroski, J. (1992). The human T-cell leukemia virus (HTLV) transactivator (TAX) protein. Biochimica et Biophysica Acta 1114, 19-29.
36. Styrt, B. A., Piazza-Hepp, T. D. & Chikami, G. K. (1996). Clinical toxicity of antiretroviral nucleoside analogs. Antiviral Research 31, 121-135.
37. Tochikura, T. S., Nakashima, H. & Yamamoto, N. (1989). Antiviral agents with activity against human retroviruses. Journal of Acquired Immune Deficiency Syndromes 2, 441-447.
38. Viora, M. & Camponeschi, B. (1995). Down-regulation of interleukin-2 receptor gene activation and protein expression by dideoxynucleoside analogs. Cellular Immunology 163, 289-295.
39. Yoshida, M., Miyoshi, I. & Hinuma, Y. (1982). Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proceedings of the National Academy of Sciences, USA 79, 2031-2035.